Abacavir sulfate is a potent nucleoside reverse transcriptase ACLACINOMYCIN 57576-44-0 inhibitor agent frequently administered in the management of human immunodeficiency virus (HIV) infection. It exerts its mechanism of action by competitively inhibiting the process of the viral reverse transcriptase enzyme, thereby preventing the conversion of HI